Product Information
NIFEDIPINE ER 60 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1709 per EA under NDC 62135052290. Its NADAC has been published 172 times since Aug 9, 2023.
FDA first approved this application on Nov 21, 2005. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Chartwell RX LLCNDC
62135052290
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
11/18/2026
Active Ingredients
NIFEDIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077127FDA Approved
11/21/2005
TE Code
AB2
On Market Since
11/21/2005
Pharmacological Classes
Price Statistics
The NADAC for NIFEDIPINE ER 60 MG TABLET has been published 172 times since Aug 9, 2023, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1709 per EA |
|---|---|
| All-time high | $0.1764 (Sep 16, 2026) |
| All-time low | $0.0982 (Nov 20, 2024) |
| 52-week high | $0.1764 |
| 52-week low | $0.1386 |
| Median price | $0.1489 |
| Average price | $0.1488 |
| Largest weekly change | -32.2% (Nov 20, 2024) |
| Weeks tracked | 172 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nifedipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NIFEDIPINE ER 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NIFEDIPINE ER 60 MG TABLET, manufactured by Chartwell RX LLC, is $0.1709 per EA (NDC 62135052290), effective Nov 18, 2026.
How has the price of NIFEDIPINE ER 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for NIFEDIPINE ER 60 MG TABLET has risen 2.5%. It has been tracked across 172 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for NIFEDIPINE ER 60 MG TABLET?
Since Aug 9, 2023, the NADAC for NIFEDIPINE ER 60 MG TABLET has ranged from a low of $0.0982 (Nov 20, 2024) to a high of $0.1764 (Sep 16, 2026), with a median of $0.1489 per EA.
Are there cheaper alternatives to NIFEDIPINE ER 60 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NIFEDIPINE ER 60 MG TABLET, is $0.1476 per EA — about 14% below NIFEDIPINE ER 60 MG TABLET.
Who manufactures NIFEDIPINE ER 60 MG TABLET?
NIFEDIPINE ER 60 MG TABLET (NDC 62135052290) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.